LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Начало・Списък с акции・Intuitive Surgical Inc

Intuitive Surgical Inc

Затворен

СекторЗдравеопазване

549.2 -2.91

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

548.95

Максимум

556.7

Ключови измерители
By Trading Economics
Приходи	45M 709M
Продажби	65M 2.5B
P/E Средно за сектора	76.318 105.69
EPS	2.4
Марж на печалбата	28.31
Служители	15,638
EBITDA	28M 1B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+11.31% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	40B 204B
Предишно отваряне	552.11
Предишно затваряне	549.2

Настроения в новините

By Acuity

14%

86%

13 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Weak Bearish Evidence

514.59 / 539.05 Подкрепа & съпротива

Intuitive Surgical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

21.10.2025 г., 23:55 ч. UTC

Горещи акции

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21.10.2025 г., 21:14 ч. UTC

Печалби

Значими двигатели на пазара

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21.10.2025 г., 20:38 ч. UTC

Печалби

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22.07.2025 г., 21:13 ч. UTC

Печалби

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22.04.2025 г., 20:55 ч. UTC

Печалби

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

30.10.2025 г., 12:38 ч. UTC

Печалби

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

30.10.2025 г., 12:01 ч. UTC

Печалби

Looking to Diversify Out of the AI Trade? Buy Boston Scientific Stock. -- Barrons.com

22.10.2025 г., 15:42 ч. UTC

Печалби

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22.10.2025 г., 12:34 ч. UTC

Печалби

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22.10.2025 г., 11:49 ч. UTC

Печалби

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21.10.2025 г., 20:08 ч. UTC

Печалби

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21.10.2025 г., 20:08 ч. UTC

Печалби

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21.10.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 3Q Rev $2.51B >ISRG

21.10.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 3Q Net $704.4M >ISRG

21.10.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21.10.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21.10.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 3Q EPS $1.95 >ISRG

22.07.2025 г., 20:14 ч. UTC

Печалби

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22.07.2025 г., 20:13 ч. UTC

Печалби

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22.07.2025 г., 20:13 ч. UTC

Печалби

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22.07.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 2Q Net $658.4M >ISRG

22.07.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22.07.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 2Q Rev $2.44B >ISRG

22.07.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22.07.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 2Q EPS $1.81 >ISRG

22.04.2025 г., 20:13 ч. UTC

Печалби

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q EPS $1.92 >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Net $698.4M >ISRG

22.04.2025 г., 20:05 ч. UTC

Печалби

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

Сравнение с други в отрасъла

Ценова промяна

Intuitive Surgical Inc Прогноза

Ценова цел

By TipRanks

11.31% нагоре

12-месечна прогноза

Среден 611.68 USD 11.31%

Висок 685 USD

Нисък 440 USD

Според 20 анализатори от Wall Street, предложили 12-месечна ценова цел за Intuitive Surgical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

20 ratings

Купи

Задържане

Продай

Според 20 анализатори, дали борсови рейтинги на Intuitive Surgical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

514.59 / 539.05Подкрепа & съпротива

Recent bearish events outweigh bullish events.

Recent bullish events outweigh bearish events.

All events are bullish.

Настроение

By Acuity

13 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.